SCHEMBL7344512

SCHEMBL7344512

O=C(O)C(OCC(F)(F)F)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CYP2J2 P51589 1/20 0.41
PPARG P37231 5/20 0.40
NPSR1 Q6W5P4 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CNR2 P34972 1/20 0.39
PLOD2 O00469 1/20 0.38
HPGD P15428 1/20 0.38
PPARA Q07869 2/20 0.37
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL893601 0.86 PDPK1 (0.44) EPHX2PPARGLMNAPPARA
SCHEMBL5642476 0.86 PDPK1 (0.44) EPHX2PPARGLMNAPPARA
SCHEMBL5640880 0.86 PDPK1 (0.44) EPHX2PPARGLMNAPPARA
Hydrochloric Acid SCHEMBL8847169 0.85 PDPK1 (0.43) EPHX2PPARGLMNAPPARA
Hydrochloric Acid SCHEMBL668327 0.85 PDPK1 (0.43) EPHX2PPARGLMNAPPARA
SCHEMBL24327731 0.79 HPGD (0.49) CYP2C9CYP2C19PPARGNPSR1MEN1
SCHEMBL17295981 0.79 HPGD (0.49) CYP2C9CYP2C19PPARGNPSR1MEN1
SCHEMBL909293 0.77 PPARG (0.40) PPARGNPSR1HPGDPPARASLC6A4
SCHEMBL8081315 0.76 GSK3B (0.45) LMNAMAPTSMN1; SMN2
SCHEMBL6388936 0.75 HPGD (0.37) CYP2C19PPARGNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6090805-A Tocolytic oxytocin receptor antagonists MERCK & CO., INC. (US) 2000-07-18 US disclosed
US-5968938-A Piperazine oxytocin receptor antagonists MERCK & CO., INC. (US) 1999-10-19 US disclosed